Despite Hamberg's FDA continuing to toughen its approach, the agency is still facing increased scrutiny from those critical of its past efforts. Even though these critics claim to be advocating for the patient, FDA's reaction may stifle innovation to the detriment of very this same group. Read today's Five-Ten blog about the latest groups to challenge the FDA, and how it may affect the device makers in the industry.